Intelligence Platform

Patents

Browse 763 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 8759302

Methods of treating a subject afflicted with an autoimmune disease using predictive biomar

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8759301

Gene fusion targeted therapy

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8748446

Halogenated compounds for photodynamic therapy

NANOQUANTUM SCIENCES, INC. · Granted Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8741880

Antiglucocorticoid therapy for the prevention of neurological damage in premature infants

Corcept Therapeutics Incorporated · Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8734778

Yeast-based vaccines as immunotherapy

The Regents of the University of Colorado · Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8709417

Combination immunotherapy for the treatment of cancer

BOARD OF REGENTS · Granted Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8703098

Labelled adrenomedullin derivatives and their use for imaging and therapy

INSTITUT DE CARDIOLOGIE DE MONTREAL · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8673888

Depsipeptide for therapy of kidney cancer

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8663635

N-cadherin: target for cancer diagnosis and therapy

The Regents of the University of California · Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8614179

Antibacterial combination therapy for the treatment of gram positive bacterial infections

E-Therapeutics PLC · Granted Tue Dec 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8609843

Photoactive metal nitrosyls for blood pressure regulation and cancer therapy

The Regents of the University of California · Granted Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8604011

Therapy for treatment of chronic degenerative brain diseases and nervous system injury

The Regents of the University of California · Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8597946

Enhanced dendritic cells for cancer immunotherapy

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8580249

Cell therapy for the treatment of lysosomal storage disorders

Regents of the University of Minnesota · Granted Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8557844

Substrate reduction therapy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8551536

Nitrite and nitrite-metheme therapy to detoxify stroma-free hemoglobin based blood substit

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8546371

Nanoparticle formulated glycolipid antigens for immunotherapy

The Board of Regents of the University of Texas System · Granted Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8546433

Axl inhibitors for use in combination therapy for preventing, treating or managing metasta

Rigel Pharmaceuticals, Inc. · Granted Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8546091

AKT phosphorylation at Ser473 as an indicator for taxane-based chemotherapy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8541185

Method of predicting responsiveness to autologous adoptive cell transfer therapy

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Sep 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8536149

TRPM-2 antisense therapy

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Sep 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8529885

AAV vectors for in vivo gene therapy of rheumatoid arthritis

ACADEMISCH MEDISCH CENTRUM · Granted Tue Sep 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8507437

Apoptosis-modulating p53 protein therapy for vascular disorders and nanoparticles containi

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8507445

Compositions and methods of use of targeting peptides for diagnosis and therapy of human c

The Board of Regents of the University of Texas System · Granted Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted